Xudong Yin, Ph.D., joined Novartis on January 18th, 2011 as Chairman of Novartis Group (China). He oversees the operation and development of the Novartis Group and of all its divisions (including Novartis Pharmaceuticals, Sandoz and Alcon) in China.

Prior to joining Novartis, Mr. Yin served as President, AstraZeneca China (including Mainland and Hong Kong), and successfully led AstraZeneca China to grow into a USD 1 billion business. Before AstraZeneca, he worked at the Boston Consulting Group, focusing on pharmaceutical industry clients in Asia.

Mr. Yin received his Bachelor’s degree in Biochemistry from Beijing University, MBA from Harvard Business School, and PhD in Biological Science from Stanford University.